Download Jordan - ICO Information Centre on HPV and Cancer

ICO Information Centre on HPV and Cancer
Jordan
Human Papillomavirus and Related Cancers, Fact Sheet 2017 (2017-04-19)
I. Key data on HPV and HPV-related cancers
1.6
0.2
Normal cytology(3)
Low−grade lesions(4)
HPV−type
Female
0.2
HPV−type
Male
No data available
1st*
2nd*
3rd*
4th*
5th*
6th*
7th*
8th*
9th*
10th*
No data available
HPV−type
Cervical cancer
Anal cancer
Vulva cancer
Vaginal cancer
Penile cancer
Pharynx (excluding nasopharynx)
1st*
2nd*
3rd*
4th*
5th*
6th*
7th*
8th*
9th*
10th*
1st*
2nd*
3rd*
4th*
5th*
6th*
7th*
8th*
9th*
10th*
No data available
HPV−type
Crude incidence rates of HPV-related
High−grade lesions(5)
Table 1.
cancers
Figure 1. Comparison of the ten most frequent HPV
oncogenic types in Jordan among women with and
without cervical lesions
Cervical Cancer(1, 2)
Jordan has a population of 2.38
millions women ages 15 years and
older who are at risk of developing cervical cancer. Current estimates indicate that every year 50
women are diagnosed with cervical cancer and 19 die from the disease. Cervical cancer ranks as the 15th most frequent cancer
among women in Jordan and the 10th most frequent cancer
among women between 15 and 44 years of age. Data is not
yet available on the HPV burden in the general population of
Jordan. However, in Western Asia, the region Jordan belongs
to, about 2.3% of women in the general population are estimated to harbour cervical HPV-16/18 infection at a given time,
and 72.4% of invasive cervical cancers are attributed to HPVs
16 or 18.
16
18
56
39
45
33
59
35
31
58
68.3
24.4
9.8
9.8
7.3
4.9
2.4
2.4
2.4
2.4
0
10
20
30
40
50
60
Prevalence (%)
Table 2. Burden of cervical cancer
∗No data available. No more types than shown were tested or were positive.
Incidence Mortality
Annual number of new cases/deaths
Crude rate
Age-standarized rate
Cumulative risk 0-74 years (%)
Ranking of cervical cancer (all years)
Ranking of cervical cancer (15-44 years)
50
1.6
2.4
0.2
15th
10th
19
0.6
1.0
0.1
17th
13th
Table 3. Burden of cervical HPV infection Jordan
No. Tested
HPV prevalence in women with normal
cytology
HPV 16/18 prevalence:
Normal cytology
Low-grade cervical lesions
High-grade cervical lesions
Cervical cancer
41
% (95% CI)
----92.7 (80.6-97.5)
For data sources and further data on HPV infection in cancer sites other than the cervix, please refer to the specific country full report.
70
ICO Information Centre on HPV and Cancer
Jordan
Human Papillomavirus and Related Cancers, Fact Sheet 2017 (2017-04-19)
II. Complementary data on cervical cancer prevention
Table 4. Factors contributing to cervical cancer (cofactors)
Table 7.
Cervical screening practices and
recommendations
Smoking prevalence (%), women
Total fertility rate (live births per women)
3.8
Cervical cancer screening coverage, % (age and
screening interval, reference)
Hormonal contraception use (%) (pill, injectable
or implant), among women
9.3
Screening ages (years)
25-35
Screening interval (years) or
frequency of screens
-
10.2
HIV prevalence (%), adults (15-49 years)
-
Table 5. Sexual behaviour
18.8% (All women aged 15-49 ever
screened, DHS 2012 Jordan)
Figure 2. Estimated coverage of cervical cancer
screening in Jordan, by age and study
MEN
Percentage of 15-year-old who have had sexual
intercourse
-
Range of median age at first sexual intercourse
-
− All women ever screened
− All women screened every 0
in 2012 −
in 2007 −
100
100
80
80
60
60
Percentage of 15-year-old who have had sexual
intercourse
0.5
Range of median age at first sexual intercourse
-
Table 6. HPV vaccine introduction
HPV vaccination programme
Date of HPV vaccination
immunization programme start
No Program
routine
HPV vaccination target age for routine
immunization
-
Estimated cervical cancer screening coverage (%)
WOMEN
40
40
26.8
25.7
19.7
20
20
11.0
-
9.2
2.8
2.7
0
0
15−19
20−34
35−49
0
0
0
0
Full course HPV vaccination coverage for
routine immunization:
% (calendar year)
-
Contact information:
ICO HPV Information Centre
Institut Català d’Oncologia
Avda. Gran Via de l’Hospitalet, 199-203
08908 L’Hospitalet de Llobregat (Barcelona, Spain)
e-mail: [email protected]
internet adress: www.hpvcentre.net
For data sources and further data on HPV infection in cancer sites other than the cervix, please refer to the specific country full report.